BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 27017245)

  • 1. The role of specimen radiography in breast-conserving therapy of ductal carcinoma in situ.
    Lange M; Reimer T; Hartmann S; Glass Ä; Stachs A
    Breast; 2016 Apr; 26():73-9. PubMed ID: 27017245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance characteristics of specimen radiography for margin assessment for ductal carcinoma in situ: a systematic review.
    Versteegden DPA; Keizer LGG; Schlooz-Vries MS; Duijm LEM; Wauters CAP; Strobbe LJA
    Breast Cancer Res Treat; 2017 Dec; 166(3):669-679. PubMed ID: 28831674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Margin index is not a reliable tool for predicting residual disease after breast-conserving surgery for DCIS.
    Fisher CS; Klimberg VS; Khan S; Gao F; Margenthaler JA
    Ann Surg Oncol; 2011 Oct; 18(11):3155-9. PubMed ID: 21947593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
    Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
    Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Operative outcomes of conventional specimen radiography versus in-operating room specimen radiography in radioactive seed-localized segmental mastectomies.
    Rhee D; Pockaj B; Wasif N; Stucky CC; Pizzitola V; Giurescu M; Patel B; McCarthy J; Gray R
    Am J Surg; 2018 Jan; 215(1):151-154. PubMed ID: 28784236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
    Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
    Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What should be the width of radiological margin to optimize resection of non-palpable invasive or in situ ductal carcinoma?
    Ouldamer L; Lechaux E; Arbion F; Body G; Vildé A
    Breast; 2014 Dec; 23(6):889-93. PubMed ID: 25456102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of introducing an in-theatre intra-operative specimen radiography (IOSR) system on the management of palpable breast cancer within a single unit.
    Layfield DM; May DJ; Cutress RI; Richardson C; Agrawal A; Wise M; Yiangou C
    Breast; 2012 Aug; 21(4):459-63. PubMed ID: 22119488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins.
    Merrill AL; Tang R; Plichta JK; Rai U; Coopey SB; McEvoy MP; Hughes KS; Specht MC; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Oct; 23(11):3453-3458. PubMed ID: 27207096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of specimen radiography in patients treated with skin-sparing mastectomy for ductal carcinoma in situ of the breast.
    Rubio IT; Mirza N; Sahin AA; Whitman G; Kroll SS; Ames FC; Singletary SE
    Ann Surg Oncol; 2000 Aug; 7(7):544-8. PubMed ID: 10947024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis.
    Vicini FA; Kestin LL; Goldstein NS
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):722-30. PubMed ID: 15465188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of lumpectomy surface with large field-of-view confocal laser scanning microscope for intraoperative margin assessment - POLARHIS study.
    Sandor MF; Schwalbach B; Hofmann V; Istrate SE; Schuller Z; Ionescu E; Heimann S; Ragazzi M; Lux MP
    Breast; 2022 Dec; 66():118-125. PubMed ID: 36240525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with residual disease after initial breast-conserving surgery for ductal carcinoma in situ.
    Wei S; Kragel CP; Zhang K; Hameed O
    Hum Pathol; 2012 Jul; 43(7):986-93. PubMed ID: 22221704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is specimen radiography still necessary in patients with non-palpable breast cancer undergoing breast-conserving surgery using radioactive I-125 seed localization?
    van Riet YE; Schipper RJ; van Merrienboer F; Orsini RG; Bloemen JG; Jansen FH; Nieuwenhuijzen GAP
    Clin Imaging; 2021 Jan; 69():311-317. PubMed ID: 33045475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of lumpectomy surgical specimen radiographs in subclinical, in situ and invasive breast cancer, and factors predicting positive margins.
    Rua C; Lebas P; Michenet P; Ouldamer L
    Diagn Interv Imaging; 2012 Nov; 93(11):871-7. PubMed ID: 23021868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery.
    Chagpar A; Yen T; Sahin A; Hunt KK; Whitman GJ; Ames FC; Ross MI; Meric-Bernstam F; Babiera GV; Singletary SE; Kuerer HM
    Am J Surg; 2003 Oct; 186(4):371-7. PubMed ID: 14553853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast specimen ultrasound and mammography in the prediction of tumour-free margins.
    Tan KY; Tan SM; Chiang SH; Tan A; Chong CK; Tay KH
    ANZ J Surg; 2006 Dec; 76(12):1064-7. PubMed ID: 17199691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying Factors and Techniques to Decrease the Positive Margin Rate in Partial Mastectomies: Have We Missed the Mark?
    Edwards SB; Leitman IM; Wengrofsky AJ; Giddins MJ; Harris E; Mills CB; Fukuhara S; Cassaro S
    Breast J; 2016 May; 22(3):303-9. PubMed ID: 26854189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Margin width is not predictive of residual disease on re-excision in breast conserving therapy.
    Hadzikadic Gusic L; McGuire KP; Ozmen T; Soran A; Thomas CR; McAuliffe PF; Diego EJ; Bonaventura M; Johnson RR; Ahrendt GM
    J Surg Oncol; 2014 Apr; 109(5):426-30. PubMed ID: 24338603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.